Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malaria

Free Subscription 15.04.2024 1 J Travel Med 2 Lancet 7 Malar J 1 Parasite Immunol 2 Trends Parasitol 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Travel Med

1. ZHU Y, Restrepo AC, Wang HB, Mills DJ, et al
   Malaria cases in China acquired through international travel, 2013-2022.
   J Travel Med. 2024 Apr 9:taae056. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Lancet

2. ASANTE KP, Mathanga DP, Milligan P, Akech S, et al
   Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
   Lancet. 2024 Apr 4:S0140-6736(24)00004-7. doi: 10.1016/S0140-6736(24)00004.
   PubMed         Abstract available
   
   
3. DAUBENBERGER CA, Silva JC
   First-generation malaria vaccine successfully implemented in three African countries.
   Lancet. 2024 Apr 4:S0140-6736(23)02892-1. doi: 10.1016/S0140-6736(23)02892.
   PubMed        
   
   

   
   Malar J

4. AHETO JMK, Menezes LJ, Takramah W, Cui L, et al
   Modelling spatiotemporal variation in under-five malaria risk in Ghana in 2016-2021.
   Malar J. 2024;23:102.
   PubMed         Abstract available
   
   
5. NGASALA BE, Chiduo MG, Mmbando BP, Francis FT, et al
   Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019.
   Malar J. 2024;23:101.
   PubMed         Abstract available
   
   
6. SIKAALA CH, Dlamini B, Lungu A, Fakudze P, et al
   Correction: Malaria elimination and the need for intensive inter-country cooperation: a critical evaluation of regional technical co-operation in Southern Africa.
   Malar J. 2024;23:98.
   PubMed        
   
   
7. MWESIGWA A, Ocan M, Musinguzi B, Nante RW, et al
   Plasmodium falciparum genetic diversity and multiplicity of infection based on msp-1, msp-2, glurp and microsatellite genetic markers in sub-Saharan Africa: a systematic review and meta-analysis.
   Malar J. 2024;23:97.
   PubMed         Abstract available
   
   
8. TANUE EA, Omam LA, Ayuk GT, Noukeme BM, et al
   A formative cross-sectional study to assess caregiver's health-seeking behaviour and knowledge surrounding malaria, and understand the burden of malaria among children under-five in conflict-affected communities of Cameroon.
   Malar J. 2024;23:99.
   PubMed         Abstract available
   
   
9. VARETA J, Horstman NA, Adams M, Seydel KB, et al
   Genotyping Plasmodium falciparum gametocytes using amplicon deep sequencing.
   Malar J. 2024;23:96.
   PubMed         Abstract available
   
   
10. NGASALA B, Chiduo MG, Bushukatale S, Mmbando BP, et al
    Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018.
    Malar J. 2024;23:95.
    PubMed         Abstract available
    
    

    
    Parasite Immunol

11. FREMPONG NA, Mama A, Adu B, Kusi KA, et al
    Antibody response to malaria vaccine candidates in pregnant women with Plasmodium falciparum and Schistosoma haematobium infections.
    Parasite Immunol. 2024;46:e13027.
    PubMed         Abstract available
    
    

    
    Trends Parasitol

12. DICKEY TH, Tolia NH
    A targetable receptor-binding site on PfCyRPA to aid in the fight against malaria.
    Trends Parasitol. 2024 Apr 10:S1471-4922(24)00083.
    PubMed         Abstract available
    
    
13. NIKULKOVA M, Abdrabou W, Carlton JM, Idaghdour Y, et al
    Exploiting integrative metabolomics to study host-parasite interactions in Plasmodium infections.
    Trends Parasitol. 2024;40:313-323.
    PubMed         Abstract available
    
    

    
    Vaccine

14. CUMMINGS JF, Polhemus ME, Kester KE, Ockenhouse CF, et al
    A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naive adults.
    Vaccine. 2024 Apr 6:S0264-410X(24)00389-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malaria is free of charge.